Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.

Kapoor A, Cai H, Forman M, He R, Shamay M, Arav-Boger R.

Antimicrob Agents Chemother. 2012 Sep;56(9):4891-9. doi: 10.1128/AAC.00898-12. Epub 2012 Jul 9.

2.

In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.

Cai H, Kapoor A, He R, Venkatadri R, Forman M, Posner GH, Arav-Boger R.

Antimicrob Agents Chemother. 2014;58(2):986-94. doi: 10.1128/AAC.01972-13. Epub 2013 Nov 25.

3.

Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.

Wang L, Wible BA, Wan X, Ficker E.

J Pharmacol Exp Ther. 2007 Feb;320(2):525-34. Epub 2006 Nov 9.

4.

Wnt modulating agents inhibit human cytomegalovirus replication.

Kapoor A, He R, Venkatadri R, Forman M, Arav-Boger R.

Antimicrob Agents Chemother. 2013 Jun;57(6):2761-7. doi: 10.1128/AAC.00029-13. Epub 2013 Apr 9.

5.

Suppression of Adenovirus Replication by Cardiotonic Steroids.

Grosso F, Stoilov P, Lingwood C, Brown M, Cochrane A.

J Virol. 2017 Jan 18;91(3). pii: e01623-16. doi: 10.1128/JVI.01623-16. Print 2017 Feb 1.

PMID:
27881644
6.

The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.

Loregian A, Mercorelli B, Muratore G, Sinigalia E, Pagni S, Massari S, Gribaudo G, Gatto B, Palumbo M, Tabarrini O, Cecchetti V, Palù G.

Antimicrob Agents Chemother. 2010 May;54(5):1930-40. doi: 10.1128/AAC.01730-09. Epub 2010 Mar 1.

7.

The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication.

Zhang H, Niu X, Qian Z, Qian J, Xuan B.

J Med Virol. 2015 Dec;87(12):2135-44. doi: 10.1002/jmv.24286. Epub 2015 Jun 16.

PMID:
26058558
8.

Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor.

Juang HH, Lin YF, Chang PL, Tsui KH.

J Urol. 2010 Nov;184(5):2158-64. doi: 10.1016/j.juro.2010.06.093. Epub 2010 Sep 17.

PMID:
20850842
9.

Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.

DeMeritt IB, Podduturi JP, Tilley AM, Nogalski MT, Yurochko AD.

Virology. 2006 Mar 1;346(1):15-31. Epub 2005 Nov 21.

10.

The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.

Mercorelli B, Luganini A, Muratore G, Massari S, Terlizzi ME, Tabarrini O, Gribaudo G, Palù G, Loregian A.

Antimicrob Agents Chemother. 2014 Nov;58(11):6615-26. doi: 10.1128/AAC.03309-14. Epub 2014 Aug 25.

11.

3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling.

Evers DL, Wang X, Huong SM, Huang DY, Huang ES.

Antiviral Res. 2004 Aug;63(2):85-95.

PMID:
15302137
12.
13.

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.

Tenney DJ, Yamanaka G, Voss SM, Cianci CW, Tuomari AV, Sheaffer AK, Alam M, Colonno RJ.

Antimicrob Agents Chemother. 1997 Dec;41(12):2680-5.

14.

Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action.

Evers DL, Chao CF, Wang X, Zhang Z, Huong SM, Huang ES.

Antiviral Res. 2005 Dec;68(3):124-34. Epub 2005 Sep 15.

PMID:
16188329
15.

Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus.

Kaspari M, Tavalai N, Stamminger T, Zimmermann A, Schilf R, Bogner E.

FEBS Lett. 2008 Mar 5;582(5):666-72. doi: 10.1016/j.febslet.2008.01.040. Epub 2008 Jan 31.

16.

Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells.

Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW.

Intervirology. 1996;39(4):259-69. Review.

PMID:
9078467
17.

Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.

Cinatl J Jr, Cinatl J, Vogel JU, Kotchetkov R, Driever PH, Kabickova H, Kornhuber B, Schwabe D, Doerr HW.

Cancer Res. 1998 Jan 15;58(2):367-72.

18.

Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.

Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gribaudo G.

Antiviral Res. 2007 Mar;73(3):175-84. Epub 2006 Oct 23.

PMID:
17070604
19.
20.

Evidence that neomycin inhibits human cytomegalovirus infection of fibroblasts.

Lobert PE, Hober D, Delannoy AS, Wattré P.

Arch Virol. 1996;141(8):1453-62.

PMID:
8856026

Supplemental Content

Support Center